The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis

Chen Yuan Chiang, Kuan Jen Bai, Hsien Ho Lin, Shun Tien Chien, Jen Jyh Lee, Donald A. Enarson, Ting I. Lee, Ming Chih Yu

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background: To assess the influence of diabetes mellitus (DM), glycemic control, and diabetes-related comorbidities on manifestations and outcome of treatment of pulmonary tuberculosis (TB). Methodology/Principal Findings: Culture positive pulmonary TB patients notified to health authorities in three hospitals in Taiwan from 2005-2010 were investigated. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C) and diabetic patients were categorized into 3 groups: HbA1C9%. 1,473 (705 with DM and 768 without DM) patients were enrolled. Of the 705 diabetic patients, 82 (11.6%) had pretreatment HbA1C9%, and 195 (27.7%) had no information of HbA1C. The proportions of patients with any symptom, cough, hemoptysis, tiredness and weight loss were all highest in diabetic patients with HbA1C>9%. In multivariate analysis adjusted for age, sex, smoking, and drug resistance, diabetic patients with HbA1C>9% (adjOR 3.55, 95% CI 2.40-5.25) and HbA1C 7-9% (adjOR 1.62, 95% CI 1.07-2.44) were significantly more likely to be smear positive as compared with non-diabetic patients, but not those with HbA1C

Original languageEnglish
Article numbere0121698
JournalPLoS One
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 30 2015

Fingerprint

glycemic control
Medical problems
Pulmonary Tuberculosis
tuberculosis
diabetes
Comorbidity
Hemoglobins
lungs
hemoglobin
diabetes mellitus
Diabetes Mellitus
Glycosylated Hemoglobin A
glycohemoglobin
Hemoptysis
cough
comorbidity
Health
drug resistance
Taiwan
Cough

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. / Chiang, Chen Yuan; Bai, Kuan Jen; Lin, Hsien Ho; Chien, Shun Tien; Lee, Jen Jyh; Enarson, Donald A.; Lee, Ting I.; Yu, Ming Chih.

In: PLoS One, Vol. 10, No. 3, e0121698, 30.03.2015.

Research output: Contribution to journalArticle

@article{14e439fef5f8454db112c8b6b2ad4a64,
title = "The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis",
abstract = "Background: To assess the influence of diabetes mellitus (DM), glycemic control, and diabetes-related comorbidities on manifestations and outcome of treatment of pulmonary tuberculosis (TB). Methodology/Principal Findings: Culture positive pulmonary TB patients notified to health authorities in three hospitals in Taiwan from 2005-2010 were investigated. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C) and diabetic patients were categorized into 3 groups: HbA1C9{\%}. 1,473 (705 with DM and 768 without DM) patients were enrolled. Of the 705 diabetic patients, 82 (11.6{\%}) had pretreatment HbA1C9{\%}, and 195 (27.7{\%}) had no information of HbA1C. The proportions of patients with any symptom, cough, hemoptysis, tiredness and weight loss were all highest in diabetic patients with HbA1C>9{\%}. In multivariate analysis adjusted for age, sex, smoking, and drug resistance, diabetic patients with HbA1C>9{\%} (adjOR 3.55, 95{\%} CI 2.40-5.25) and HbA1C 7-9{\%} (adjOR 1.62, 95{\%} CI 1.07-2.44) were significantly more likely to be smear positive as compared with non-diabetic patients, but not those with HbA1C",
author = "Chiang, {Chen Yuan} and Bai, {Kuan Jen} and Lin, {Hsien Ho} and Chien, {Shun Tien} and Lee, {Jen Jyh} and Enarson, {Donald A.} and Lee, {Ting I.} and Yu, {Ming Chih}",
year = "2015",
month = "3",
day = "30",
doi = "10.1371/journal.pone.0121698",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis

AU - Chiang, Chen Yuan

AU - Bai, Kuan Jen

AU - Lin, Hsien Ho

AU - Chien, Shun Tien

AU - Lee, Jen Jyh

AU - Enarson, Donald A.

AU - Lee, Ting I.

AU - Yu, Ming Chih

PY - 2015/3/30

Y1 - 2015/3/30

N2 - Background: To assess the influence of diabetes mellitus (DM), glycemic control, and diabetes-related comorbidities on manifestations and outcome of treatment of pulmonary tuberculosis (TB). Methodology/Principal Findings: Culture positive pulmonary TB patients notified to health authorities in three hospitals in Taiwan from 2005-2010 were investigated. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C) and diabetic patients were categorized into 3 groups: HbA1C9%. 1,473 (705 with DM and 768 without DM) patients were enrolled. Of the 705 diabetic patients, 82 (11.6%) had pretreatment HbA1C9%, and 195 (27.7%) had no information of HbA1C. The proportions of patients with any symptom, cough, hemoptysis, tiredness and weight loss were all highest in diabetic patients with HbA1C>9%. In multivariate analysis adjusted for age, sex, smoking, and drug resistance, diabetic patients with HbA1C>9% (adjOR 3.55, 95% CI 2.40-5.25) and HbA1C 7-9% (adjOR 1.62, 95% CI 1.07-2.44) were significantly more likely to be smear positive as compared with non-diabetic patients, but not those with HbA1C

AB - Background: To assess the influence of diabetes mellitus (DM), glycemic control, and diabetes-related comorbidities on manifestations and outcome of treatment of pulmonary tuberculosis (TB). Methodology/Principal Findings: Culture positive pulmonary TB patients notified to health authorities in three hospitals in Taiwan from 2005-2010 were investigated. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C) and diabetic patients were categorized into 3 groups: HbA1C9%. 1,473 (705 with DM and 768 without DM) patients were enrolled. Of the 705 diabetic patients, 82 (11.6%) had pretreatment HbA1C9%, and 195 (27.7%) had no information of HbA1C. The proportions of patients with any symptom, cough, hemoptysis, tiredness and weight loss were all highest in diabetic patients with HbA1C>9%. In multivariate analysis adjusted for age, sex, smoking, and drug resistance, diabetic patients with HbA1C>9% (adjOR 3.55, 95% CI 2.40-5.25) and HbA1C 7-9% (adjOR 1.62, 95% CI 1.07-2.44) were significantly more likely to be smear positive as compared with non-diabetic patients, but not those with HbA1C

UR - http://www.scopus.com/inward/record.url?scp=84926360830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926360830&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0121698

DO - 10.1371/journal.pone.0121698

M3 - Article

C2 - 25822974

AN - SCOPUS:84926360830

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0121698

ER -